These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 2547501

  • 21. Erythrocyte Na/K-ATPase is increased in subjects with subclinical hypothyroidism.
    Nicolini G, Balzan S, Colzani R, Scarlattini M, Taddei MC, Iervasi G.
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):705-10. PubMed ID: 15163334
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Increase in plasma ouabainlike inhibitor of Na+, K+-ATPase with high sodium intake in patients with essential hypertension.
    Hasegawa T, Masugi F, Ogihara T, Kumahara Y.
    J Clin Hypertens; 1987 Dec; 3(4):419-29. PubMed ID: 2839625
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Comparison of low-molecular-weight plasma and urine Na-K-ATPase inhibitors/hypertensive factors.
    Gonick HC, Weiler EW, Prins BA, Purdy RE.
    J Cardiovasc Pharmacol; 1993 Dec; 22 Suppl 2():S69-71. PubMed ID: 7508033
    [Abstract] [Full Text] [Related]

  • 29. Significant difference in the effect of acute saline loading on plasma Na-K ATPase inhibitor and blood pressure between children and adults with essential hypertension.
    Uchiyama M, Sakai K.
    Nihon Jinzo Gakkai Shi; 1992 Jan; 34(1):91-7. PubMed ID: 1317474
    [Abstract] [Full Text] [Related]

  • 30. Predominance of high molecular weight plasma Na(+)-K(+)-ATPase inhibitor in essential hypertension.
    Gonick HC, Weiler EW, Khalil-Manesh F, Weber MA.
    Am J Hypertens; 1993 Aug; 6(8):680-7. PubMed ID: 8217031
    [Abstract] [Full Text] [Related]

  • 31. Lysophosphatidylcholines containing polyunsaturated fatty acids were found as Na+, K+-ATPase inhibitors in acutely volume-expanded hog.
    Tamura M, Harris TM, Higashimori K, Sweetman BJ, Blair IA, Inagami T.
    Biochemistry; 1987 May 19; 26(10):2797-806. PubMed ID: 3038164
    [Abstract] [Full Text] [Related]

  • 32. Heparin, fatty acids and sodium, potassium-ATPase inhibition by plasma factors during hemodialysis.
    Gault MH, Vasdev SC, Longerich L, Purchase L, Sampson C, Johnson E.
    Nephron; 1992 May 19; 60(3):292-301. PubMed ID: 1314335
    [Abstract] [Full Text] [Related]

  • 33. Characteristics of a (Na+-K+)-ATPase inhibitor in extracts of tea.
    Sagnella GA, MacGregor GA.
    Am J Clin Nutr; 1984 Jul 19; 40(1):36-41. PubMed ID: 6331148
    [Abstract] [Full Text] [Related]

  • 34. Isolation and characterization of a specific endogenous Na+,K+-ATPase inhibitor from bovine adrenal.
    Tamura M, Lam TT, Inagami T.
    Biochemistry; 1988 Jun 14; 27(12):4244-53. PubMed ID: 2844224
    [Abstract] [Full Text] [Related]

  • 35. Characteristics of a ouabain-like factor from Milan hypertensive rats.
    Ferrandi M, Minotti E, Salardi S, Florio M, Bianchi G, Ferrari P.
    J Cardiovasc Pharmacol; 1993 Jun 14; 22 Suppl 2():S75-8. PubMed ID: 7508036
    [Abstract] [Full Text] [Related]

  • 36. Direct demonstration of an inhibitor of sodium, potassium dependent adenosine triphosphatase (Na+, K+-ATPase) in plasma from normotensive and hypertensive subjects.
    Roulston JE, Traill K, Wathen CG.
    Clin Chim Acta; 1986 Sep 15; 159(2):163-71. PubMed ID: 3021362
    [Abstract] [Full Text] [Related]

  • 37. Partial purification and properties of a plasma ouabain-like inhibitor of Na+, K+-ATPase in patients with essential hypertension.
    Masugi F, Ogihara T, Sakaguchi K, Tomii A, Hasegawa T, Chen Y, Azuma M, Kumahara Y.
    J Hypertens Suppl; 1988 Dec 15; 6(4):S351-3. PubMed ID: 2853743
    [Abstract] [Full Text] [Related]

  • 38. Endogenous digitalis-like factors in hypertension and chronic renal insufficiency.
    Kelly RA, O'Hara DS, Mitch WE, Steinman TI, Goldszer RC, Solomon HS, Smith TW.
    Kidney Int; 1986 Nov 15; 30(5):723-9. PubMed ID: 3023736
    [Abstract] [Full Text] [Related]

  • 39. Affinity chromatography for human Na+, K+-ATPase inhibitors in plasma and urine.
    Henning G, Cloix JF, Wainer IW, Pernollet MG, Devynck MA, Meyer P.
    Life Sci; 1985 May 06; 36(18):1787-98. PubMed ID: 2984510
    [Abstract] [Full Text] [Related]

  • 40. Erythrocyte Na+,K(+)-ATPase properties and adenylate energy charge in normotensives and in essential hypertensives.
    Canestrari F, Galli F, Boschi S, Albertini MC, Gheller G, De Crescentini S, Bossú M.
    Clin Chim Acta; 1994 Jan 31; 224(2):167-79. PubMed ID: 8004787
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.